Scinai Immunotherapeutics (SCNI) Stock Price, Quote, News & History

Scinai Immunotherapeutics Ltd (SCNI) Stock Price, Quote, News & History

SCNINASDAQ

Trade with Public

$0.6000

-0.0391-6.12%

At close: Apr 2, 5:00 PM EST

$0.5880

-0.012-2.00%

After Hours: Apr 2, 4:31 PM EST

Earnings: FY 2025 Earnings were released on Wed Apr 1st, before the market open

Key Statistics

Open

$0.62

$0.60

Volume / Avg.

37.23K / 52.01K

Day Range

$0.57 - $0.62

52 Wk Range

0.55 - 6.18

Market Cap

$2.04M

P/E Ratio

0.16

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

2.17%

Days to Cover

Recent Scinai Immunotherapeutics Ltd News

Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Avi Kapoor

Crude Oil Moves Lower; Goldman Sachs Posts Upbeat Results

Avi Kapoor

Why SolarEdge Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-5.69M

Investing Cash Flow (TTM)

-16.00K

Financing Cash Flow (TTM)

3.59M

Free Cash Flow (TTM)

-5.71M

Capital Expenditure (TTM)

-16.00K

Net Change in Cash (TTM)

-2.24M

Valuation Metrics

Enterprise Value

$8.31M

PE Ratio (TTM)

0.16

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

0.72

PB Ratio (TTM)

0.98

Earnings Yield % (TTM)

634.42%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

1.13

Price / EBITDA (TTM)

0.10

Price / Free Cash Flow (TTM)

Book Value / Share

$0.64

Company Debt

Total Debt

$293.00K

LT Debt

$293.00K

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$989.00K

Debt to Equity

1.06

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$0.62

$0.60

Volume / Avg.

37.23K / 52.01K

Day Range

$0.57 - $0.62

52 Wk Range

0.55 - 6.18

Market Cap

$2.04M

P/E Ratio

0.16

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

2.17%

Days to Cover

About

Sector

Health Care

Industry

Biotechnology

Scinai Immunotherapeutics Ltd is a biopharmaceutical company with two complementary business units, one focused on in-house development of inflammation and immunology (I&I) biological therapeutic products beginning with a pipeline of nanosized VHH an...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Scinai Immunotherapeutics (SCNI) stock?

You can purchase shares of Scinai Immunotherapeutics (NASDAQ:SCNI) through any online brokerage.

View our list of the best stock brokerages

Who are Scinai Immunotherapeutics (SCNI) competitors?

Other companies in Scinai Immunotherapeutics’s space includes: Ernexa Therapeutics Inc (NASDAQ:ERNAW), Geovax Labs Inc (NASDAQ:GOVX), Genprex Inc (NASDAQ:GNPX), AquaBounty Technologies Inc (NASDAQ:AQB) and Apimeds Pharmaceuticals Us Inc (AMEX:APUS).

What is the forecast, or price target, for Scinai Immunotherapeutics (SCNI) stock?

There is no analysis for Scinai Immunotherapeutics to provide a consensus price target.

What is the current price for Scinai Immunotherapeutics (SCNI)?

The stock price for Scinai Immunotherapeutics (NASDAQ: SCNI) is $0.588 last updated April 2, 2026 at 4:31 PM EDT.

Does Scinai Immunotherapeutics (SCNI) pay a dividend?

There are no upcoming dividends for Scinai Immunotherapeutics.

When is Scinai Immunotherapeutics (NASDAQ:SCNI) reporting earnings?

Scinai Immunotherapeutics does not have any upcoming earnings scheduled.

Is Scinai Immunotherapeutics (SCNI) going to split?

There is no upcoming split for Scinai Immunotherapeutics.

What sector and industry does Scinai Immunotherapeutics (SCNI) operate in?

Scinai Immunotherapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

ERNAW

AquaBounty Technologies Inc

NASDAQ:AQB

$0.89

1.66%

Apimeds Pharmaceuticals Us Inc

AMEX:APUS

$1.81

-3.72%

Biodexa Pharmaceuticals PLC

NASDAQ:BDRX

$0.84

-3.46%

Ensysce Biosciences Inc

Key Statistics

Open

$0.62

$0.60

Volume / Avg.

37.23K / 52.01K

Day Range

$0.57 - $0.62

52 Wk Range

0.55 - 6.18

Market Cap

$2.04M

P/E Ratio

0.16

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

2.17%

Days to Cover

Recent Scinai Immunotherapeutics Ltd News

Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Avi Kapoor

Crude Oil Moves Lower; Goldman Sachs Posts Upbeat Results

Avi Kapoor

Why SolarEdge Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-5.69M

Investing Cash Flow (TTM)

-16.00K

Financing Cash Flow (TTM)

3.59M

Free Cash Flow (TTM)

-5.71M

Capital Expenditure (TTM)

-16.00K

Net Change in Cash (TTM)

-2.24M

Valuation Metrics

Enterprise Value

$8.31M

PE Ratio (TTM)

0.16

PE Ratio (FWD)

PEG Ratio (TTM)

PS Ratio (TTM)

0.72

PB Ratio (TTM)

0.98

Earnings Yield % (TTM)

634.42%

Earnings Yield % (FWD)

EV / EBITDA (TTM)

1.13

Price / EBITDA (TTM)

0.10

Price / Free Cash Flow (TTM)

Book Value / Share

$0.64

Company Debt

Total Debt

$293.00K

LT Debt

$293.00K

LT Debt Issuance (TTM)

LT Debt Repayment (TTM)

Total Cash

$989.00K

Debt to Equity

1.06

Issuance of Debt (TTM)

Repayment of Debt (TTM)

Key Statistics

Open

$0.62

$0.60

Volume / Avg.

37.23K / 52.01K

Day Range

$0.57 - $0.62

52 Wk Range

0.55 - 6.18

Market Cap

$2.04M

P/E Ratio

0.16

Dividend Yield

Exchange

NASDAQ

RSI

Short Interest

2.17%

Days to Cover

About

Sector

Health Care

Industry

Biotechnology

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry